Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Opin Emerg Drugs. 2008 Mar;13(1):53-62. doi: 10.1517/14728214.13.1.53 .

Emerging therapies for fibromyalgia.

Author information

  • 1Tel Aviv Sourasky Medical Center, Rheumatology Institute, Tel Aviv, Israel.

Abstract

BACKGROUND:

Fibromyalgia syndrome (FMS) is a disorder characterized by widespread pain, tenderness, and fatigue. High prevalence marks the syndrome which is considered to reflect altered central pain processing. Fibromyalgia syndrome runs a chronic, non-progressive course, extracting high price owing to impaired quality of life, restricted vocational capacity, and increased health care utilization.

OBJECTIVE:

To review current and emerging trends in the treatment of FMS.

METHODS:

A rigorous search of published literature, abstract presentations, and industry provided data was performed.

RESULTS/CONCLUSION:

The recent FDA approval of pregabalin as a first specific medication for FMS may herald a new era for the development of medications with higher specificity and efficacy for this hitherto frustrating condition.

PMID:
18321148
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk